Based on these results, there is a strong possibility that the anti-NAFLD effect of active androgens, converted from adrenal sex steroid precursors, is exerted through the indirect inactivation of hepatic SREBF1 signaling in young females. This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.